Skip to main content
. Author manuscript; available in PMC: 2013 Nov 24.
Published in final edited form as: Small. 2011 Dec 5;8(3):10.1002/smll.201101718. doi: 10.1002/smll.201101718

Figure 3.

Figure 3

Co-transfection data in IMR90 human fibroblasts. B4S4E7 and B5S3E7-based nanoparticles were used to deliver EGFP and DsRed plasmids within the same particles on the same day as well as a) within separate particles on separate days and b) within separate particles on the same day. Lipofectamine 2000 was used as a positive control.

HHS Vulnerability Disclosure